home · filing · 0001420720-22-000006
8-K filed May 2, 2022, 7:59 PM ET
ticker IBIO
CIK 0001420720
leadership
confidence high
sentiment neutral
materiality 0.50
iBio COO Randy Maddux resigns effective May 2, 2022; stays as consultant at $10k/month
iBio, Inc.
COO Randy Maddux resigned effective May 2, 2022; no disagreement with the company.
Mike Jenkins, VP of Operations, will lead transition of COO responsibilities.
Maddux entered a 12-month consulting agreement for $10,000/month as strategic advisor.
Consulting agreement may be terminated by either party without cause after initial 12 months.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Randy J. Maddux
Chief Operating Officer
Effective 2022-05-02
Filed May 2, 2022, 7:59 PM ET
On April 28, 2022, the Company received the resignation of Randy J. Maddux, its Chief Operating Officer, effective May 2, 2022.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Randy J. Maddux resigned as Chief Operating Officer at iBio, Inc..
Action resigned
Role Chief Operating Officer
Exact text from the filing
On April 28, 2022, the Company received the resignation of Randy J. Maddux, its Chief Operating Officer, effective May 2, 2022.
View on SEC.gov
Source: SEC EDGAR
accession 0001420720-22-000006
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.